Ask your doctor which of these walking exoskeletons will get you 100% recovered, meaning walking without the exoskeleton.
There are many more exoskeletons out there. Which ones has your hospital tested?
Maybe these?
5-Link model based gait trajectory adaption control strategies of the gait rehabilitation exoskeleton for post-stroke patients August 2020
A Control Framework of Lower Extremity Rehabilitation Exoskeleton based on Neuro-Muscular-Skeletal Model.pdf August 2020
Passive-elastic knee-ankle exoskeleton reduces the metabolic cost of walking July 2020
Effects of a wearable exoskeleton stride management assist system (SMA®) on spatiotemporal gait characteristics in individuals after stroke: a randomized controlled trial June 2020
The H2 robotic exoskeleton for gait rehabilitation after stroke: early findings from a clinical study May 2020
Gait training early after stroke with a new exoskeleton--the hybrid assistive limb: a study of safety and feasibility April 2020
Gait training early after stroke with a new exoskeleton--the hybrid assistive limb: a study of safety and feasibility January 2020
I gave up listing them all, it is your doctor's job to know this.
Your doctor can analyze the intersection of these three sets of data.
In the USA, the use of the Atlanta exoskeleton is approved for the rehabilitation of patients
The US Food and Drug Administration has approved the use of exoskeletons in the rehabilitation of stroke survivors.
It is about the Atlanta exoskeleton produced by the Wandercraft company, which can help with intensive walking training, especially for people with limited mobility of the upper body, Telegraph reports.
The current generation of the Atlanta exoskeleton is a self-balancing, battery-powered device with an adjustable gait that can help with early steps that lead to more natural walking later in therapy.
Although the device still needs to be used in a clinical setting with the help of a therapist, its use allows patients to walk again, whether they can use their hands or not.
Wandercraft plans to ship the first units of its exoskeleton to the US during the first quarter of the year, but the first customers have not been named.
It recently launched a commercial business, but Quadrant Management, which is a financial backer, claims Wandercraft can "significantly grow" its business in the next one to two years.
Previously FDA-approved exoskeletons are still rare and limited to help with specific conditions. In June of last year, the company Ekso Bionics received the license to sell its EksoNR device intended for the rehabilitation of patients with multiple sclerosis.
Wandercraft's exoskeleton license could be especially meaningful to patients, given that strokes are a leading cause of long-term disability in the US.
More than 790 people suffer a stroke in the US each year, and an exoskeleton could help at least some of them regain freedom of movement. /Telegraph/
No comments:
Post a Comment